What is Refuah Physical Therapy?
Refuah Physical Therapy operates as a premier provider of physical and occupational therapy, with a concentrated footprint in Brooklyn and Staten Island. The company distinguishes itself through a personalized, one-on-one treatment model that addresses a wide spectrum of patient needs, ranging from elite athletic performance recovery to chronic pain management and daily mobility restoration. By integrating clinical expertise with a patient-centric philosophy, the firm has established a reputation for delivering efficient, evidence-based rehabilitation plans that prioritize long-term wellness and functional independence.
The company's market position is defined by its ability to bridge the gap between specialized medical care and community-based wellness. As a key player in the regional healthcare landscape, Refuah Physical Therapy utilizes its clinical proficiency to drive patient outcomes, effectively positioning itself as a leader in the outpatient rehabilitation market.
How much funding has Refuah Physical Therapy raised?
Refuah Physical Therapy has raised a total of $335K across 2 funding rounds:
Debt
$150K
Debt
$185K
Debt (2020): $150K with participation from PPP
Debt (2021): $185K led by PPP
Key Investors in Refuah Physical Therapy
PPP
Public-Private Partnership
Undisclosed Investor
An undisclosed investor participating in the funding round to support the company's long-term strategic objectives.
Undisclosed Investor
An undisclosed investor participating in the funding round to support the company's long-term strategic objectives.
What's next for Refuah Physical Therapy?
With the successful acquisition of $185K, Refuah Physical Therapy is well-positioned to accelerate its strategic growth initiatives. The firm is expected to focus on expanding its clinical capacity and potentially broadening its geographic reach within the New York region. Future developments will likely center on the integration of advanced therapeutic technologies and the optimization of patient care workflows to sustain its high-growth trajectory.
As the company transitions into this next phase of development, the focus will remain on scaling its operational model while maintaining the high standard of personalized care that has become its hallmark. Investors and stakeholders will be monitoring the firm's ability to leverage this capital to capture additional market share and solidify its status as a dominant force in the physical therapy industry.
